Monopar Therapeutics Inc
XNAS: MNPR
Monopar Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prev...
Read More
41.18
-1.48
(-3.47%)
9,915
XNAS Volume
XNAS 31 Jul, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Monopar Therapeutics Inc is on 08 Aug 2025 for the purpose of Monopar Therapeutics Inc Second Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Monopar Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..